These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Role of antibodies and antibiotics in aerobic gram-negative septicemia: possible synergism between antimicrobial treatment and immunotherapy. Overbeek BP; Veringa EM Rev Infect Dis; 1991; 13(4):751-60. PubMed ID: 1925294 [TBL] [Abstract][Full Text] [Related]
83. Rapid Analysis of Bacterial Contamination in Platelets without Pre-Enrichment Using Pig Serum-Derived Antibodies. Bong JH; Park JH; Sung JS; Lee CK; Lee GY; Kang MJ; Kim HO; Pyun JC ACS Appl Bio Mater; 2021 Nov; 4(11):7779-7789. PubMed ID: 35006761 [TBL] [Abstract][Full Text] [Related]
84. The function of antibody and complement in the lysis of bacteria. Frank MM; Joiner K; Hammer C Rev Infect Dis; 1987; 9 Suppl 5():S537-45. PubMed ID: 3317749 [TBL] [Abstract][Full Text] [Related]
85. Major heat-modifiable outer membrane protein in gram-negative bacteria: comparison with the ompA protein of Escherichia coli. Beher MG; Schnaitman CA; Pugsley AP J Bacteriol; 1980 Aug; 143(2):906-13. PubMed ID: 7009566 [TBL] [Abstract][Full Text] [Related]
86. Effect of lethal doses of complement on the functional integrity of target enterobacteria. Taylor PW; Kroll HP Curr Top Microbiol Immunol; 1985; 121():135-58. PubMed ID: 3910366 [No Abstract] [Full Text] [Related]
87. Characterization of two different antibody specificities recognizing distinct antigenic determinants in free lipid A of Escherichia coli. Brade L; Brade H Infect Immun; 1985 Jun; 48(3):776-81. PubMed ID: 2581900 [TBL] [Abstract][Full Text] [Related]
89. Outer membrane proteins: key players for bacterial adaptation in host niches. Lin J; Huang S; Zhang Q Microbes Infect; 2002 Mar; 4(3):325-31. PubMed ID: 11909743 [TBL] [Abstract][Full Text] [Related]
90. A new technique for determination of immobilizing antibodies against E. coli using capillary tubes. Kaijser B Int Arch Allergy Appl Immunol; 1981; 64(2):167-70. PubMed ID: 7007255 [TBL] [Abstract][Full Text] [Related]
92. Prophylactic role for antibodies to Escherichia coli J5. Gould FK; Freeman R Lancet; 1987 Jan; 1(8526):215. PubMed ID: 2880037 [No Abstract] [Full Text] [Related]
93. Interaction of Gram-negative bacteria with cationic proteins: Dependence on the surface characteristics of the bacterial cell. Prokhorenko IR; Zubova SV; Ivanov AY; Grachev SV Int J Gen Med; 2009 Jul; 2():33-8. PubMed ID: 20360884 [TBL] [Abstract][Full Text] [Related]
94. Endotoxic properties of gramnegative bacteria and their susceptibility to the lethal effect of normal serum. MICHAEL JG; LANDY M J Infect Dis; 1961; 108():90-4. PubMed ID: 13770152 [No Abstract] [Full Text] [Related]
95. Effectivity of colon immune serum, with special reference to the L antibody. EWERTSEN HW Acta Pathol Microbiol Scand; 1947; 24(3-4):251-9. PubMed ID: 18900893 [No Abstract] [Full Text] [Related]
97. Mucoid enhancing antibody in homologous antiserum for Escherichia coli. WUST CJ J Bacteriol; 1959 Apr; 77(4):452-60. PubMed ID: 13641209 [No Abstract] [Full Text] [Related]
98. Comparison of the envelope protein compositions of several gram-negative bacteria. Schnaitman CA J Bacteriol; 1970 Dec; 104(3):1404-5. PubMed ID: 16559124 [TBL] [Abstract][Full Text] [Related]